The Patent Finder
US

Anti C-Met Antibodies

US 11,673,960 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Lockbody Therapeutics Ltd., an earlier holder on the record. The recorded assignments below show how it moved.

Term ends May 16, 2039 · High confidence

Filed Sep 11, 2020 as application 16/980,015 · Granted Jun 13, 2023
Base term plus 65 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2019 2039
Clock starts
Mar 12, 2019
Term ends
May 16, 2039
Granted
Jun 13, 2023
base term patent term adjustment Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
65
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 65 days past its 20-year base term on prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Mar 12, 2019, when application PCT/EP2019/056178, the earliest non-provisional in its chain, was filed (this one was filed Sep 11, 2020)Mar 12, 2039High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+65 days, USPTO patent term adjustment recordMay 16, 2039High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderMay 16, 2039High confidence

This family

US 11,673,960this patent
May 2039
May 2039
US 12,415,861In force
Apr 2039
Apr 2039
Application 19/304,080Pending
not computed
not computed
3 of 4 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Sep 23, 2020
Reel 53856, frame 961
Finlay, William James JonathanUltrahuman Six LimitedAssignment of Assignor's Interest
Nov 24, 2020
Reel 54461, frame 27
Ultrahuman Six LimitedLockbody Therapeutics Ltd.Change of Name
Oct 4, 2021
Reel 57710, frame 82
Apcintex Limited; Janpix Limited; Capella Bioscience Ltd.; Lockbody Therapeutics Ltd.; Ultrahuman Two Limited; Ultrahuman Four Limited; Morphogen-IX Limited; Orexia Therapeutics Limited; Cardiokine Biopharma LLC; Palladio Biosciences, Inc.; Pearlriver Bio GmbH; Z Factor LimitedCocoon S.A. LLCSecurity Interest
May 20, 2022
Reel 61603, frame 778
Lockbody Therapeutics Ltd.Lockbody Therapeutics Ltd.Change of Address
Oct 20, 2023
Reel 65293, frame 294
Lockbody Therapeutics Ltd.Centessa Pharmaceuticals (UK) LimitedAssignment of Assignor's Interest
Dec 31, 2024
Reel 69708, frame 39
Centessa Pharmaceuticals (UK) LimitedOxford Finance LLCSecurity Interest
Jun 12, 2026
Reel 75737, frame 1
Cocoon S.A. LLCApcintex Limited; Janpix Limited; Capella Bioscience Ltd.; Lockbody Therapeutics Ltd.; Ultrahuman Two Limited; Ultrahuman Four Limited; Morphogen-IX Limited; Orexia Therapeutics Limited; Cardiokine Biopharma LLC; Centessa Biosciences, Inc.; Pearlriver Bio GmbH; Z Factor LimitedRelease of Security Interest
Jun 12, 2026
reel/frame not recorded
Cocoon S.A. LLCApcintex LimitedRelease of Security Interest
Jun 12, 2026
reel/frame not recorded
Cocoon S.A. LLCJanpix LimitedRelease of Security Interest
Jun 12, 2026
reel/frame not recorded
Cocoon S.A. LLCCapella Bioscience Ltd.Release of Security Interest
Jun 12, 2026
reel/frame not recorded
Cocoon S.A. LLCLockbody Therapeutics Ltd.Release of Security Interest
Jun 12, 2026
reel/frame not recorded
Cocoon S.A. LLCUltrahuman Two LimitedRelease of Security Interest
Jun 12, 2026
reel/frame not recorded
Cocoon S.A. LLCUltrahuman Four LimitedRelease of Security Interest
Jun 12, 2026
reel/frame not recorded
Cocoon S.A. LLCMorphogen-IX LimitedRelease of Security Interest
Jun 12, 2026
reel/frame not recorded
Cocoon S.A. LLCOrexia Therapeutics LimitedRelease of Security Interest
Jun 12, 2026
reel/frame not recorded
Cocoon S.A. LLCCardiokine Biopharma LLCRelease of Security Interest
Jun 12, 2026
reel/frame not recorded
Cocoon S.A. LLCCentessa Biosciences, Inc.Release of Security Interest
Jun 12, 2026
reel/frame not recorded
Cocoon S.A. LLCPearlriver Bio GmbHRelease of Security Interest
Jun 12, 2026
reel/frame not recorded
Cocoon S.A. LLCZ Factor LimitedRelease of Security Interest
Jun 24, 2026
Reel 75069, frame 879
Oxford Finance LLCCentessa Pharmaceuticals (UK) LimitedRelease of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited